Publication:
Key interactions of the mutant HIV-1 reverse transcriptase/efavirenz: An evidence obtained from ONIOM method

dc.contributor.authorBoonsri P.
dc.contributor.authorKuno M.
dc.contributor.authorHannongbua S.
dc.date.accessioned2021-04-05T03:34:50Z
dc.date.available2021-04-05T03:34:50Z
dc.date.issued2011
dc.date.issuedBE2554
dc.description.abstractTwo-layered ONIOM calculations were performed in order to compare the binding of efavirenz (EFV) to the HIV-1 RT binding pocket of both wild type (WT) and K103N enzymes. The K103N mutation reduces the binding affinity of the inhibitor by 5.81 kcal mol -1 as obtained from the ONIOM2 (B3LYP/6-31G(d,p):PM3) method. These indicate that the loss of binding energy to K103N mutation can attribute to a weakened attractive interaction between the drug and residues surrounding in the binding pocket. The deformation of the K103N binding pocket requires more energy for structural rearrangement than that of the WT by approximately 4.0 kcal mol -1. Moreover, the pairwise energies perfectly demonstrate that the K103N mutation affects on the loss of the interaction energy. In addition, the main influences are due to residues surrounding in the binding pocket; K101, K102, S105, V179, W229, P236 and E138. In particular, two residues; K101 and S105, established hydrogen bondings with the inhibitor. ONIOM calculations, resulting in the details of binding energy, interaction energy and deformation energy can be used to identify the key interaction and structural requirements of more potent HIV-1 RT inhibitor. © 2011 The Royal Society of Chemistry.
dc.format.mimetypeapplication/pdf
dc.identifier.citationMedChemComm. Vol 2, No.12 (2011), p.1181-1187
dc.identifier.doi10.1039/c1md00162k
dc.identifier.issn20402503
dc.identifier.other2-s2.0-82455186221
dc.identifier.urihttps://hdl.handle.net/20.500.14740/7214
dc.rights.holderScopus
dc.subject.otherEfavirenz
dc.subject.otherRNA directed DNA polymerase
dc.subject.otherAmino acid sequence
dc.subject.otherArticle
dc.subject.otherBinding affinity
dc.subject.otherBinding kinetics
dc.subject.otherBinding site
dc.subject.otherDrug interaction
dc.subject.otherDrug protein binding
dc.subject.otherEnergy
dc.subject.otherEnzyme structure
dc.subject.otherHydrogen bond
dc.subject.otherMathematical analysis
dc.subject.otherMutant
dc.subject.otherPriority journal
dc.subject.otherWild type
dc.titleKey interactions of the mutant HIV-1 reverse transcriptase/efavirenz: An evidence obtained from ONIOM method
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-82455186221&doi=10.1039%2fc1md00162k&partnerID=40&md5=f5396527d4ea290686b48e2572eafa0a

Files